Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Two vaccines for HPV prove effective in clinical trials

Oct. 31, 2001

Sankyo presents new inhibitors of macrophage activity

Oct. 24, 2001

Antex concludes Phase I of SBIR grant from U.S. Army

Oct. 23, 2001

Oxamide-based inhibitors of IMPDH under study at Roche

Oct. 11, 2001

Xenova terminates TA-HSV development, DISC-PRO studies continue

Oct. 11, 2001

ABX-CBL promising for the management of GVHD according to phase II trial

Oct. 9, 2001

Good stability, favorable pharmacokinetics determined for LJP-920

Oct. 3, 2001

Enrollment completed for phase I/II StreptAvax trial

Sep. 28, 2001

Potential therapy for GVHD continues in late-stage clinical development

Sep. 27, 2001

Second orphan drug designation received for orBec in GVHD

Sep. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...